Schuchart Aaron
Insider CIK 1709258 · (LUMO) Chief Business Officer · AGLE Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 8,500 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 7,805 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 45,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 8,179 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2024-04-01 | 2024-04-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2024-04-01 | 2024-04-03 | 1,000 | $2.84 | $2.8K | 6,679 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-02-01 | 2024-02-05 | 202 | $3.01 | $608 | 5,679 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2023-02-01 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2023-02-01 | 2023-02-03 | 1,000 | $3.52 | $3.5K | 5,485 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-02-01 | 2023-02-03 | 104 | $3.52 | $366 | 5,381 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2022-02-01 | 2022-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-02-01 | 2022-02-03 | 52 | $10.02 | $521 | 3,985 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2022-02-01 | 2022-02-03 | 1,000 | $10.02 | $10.0K | 4,037 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2021-08-12 | 2021-08-13 | 1,700 | $7.42 | $12.6K | 3,037 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2021-08-11 | 2021-08-13 | 300 | $7.35 | $2.2K | 1,337 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-06-01 | 2021-06-03 | 7,805 | — | $0 | 7,805 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-02-28 | 2019-03-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-09-27 | 2018-09-28 | 5,900 | $9.50 | $56.0K | 2,500 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | S Sale | 2018-09-27 | 2018-09-28 | 100 | $9.55 | $955 | 8,400 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-08-17 | 2018-08-21 | 8,500 | — | $0 | 91,500 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-08-17 | 2018-08-21 | 8,500 | $3.50 | $29.8K | 8,500 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-02-20 | 2018-02-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-08-22 | 2017-08-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-06-16 | 2017-06-20 | 100,000 | — | $0 | 100,000 | SEC↗ |